Prodotti della ricerca

 

UNICA IRIS Institutional Research Information System

IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Cagliari dal mese di luglio 2015.

Mostra risultati da 21 a 40 di 75
successivo >  < precedente 
TitoloData di pubblicazioneAutore(i)RivistaEditore
Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.2009Brunetto MR; Moriconi F; Bonino F; Lau GK; Farci P; Yurdaydin C; Piratvisuth T; Luo K; Wang Y; Ha...dziyannis S; Wolf E; McCloud P; Batrla R; Marcellin P.HEPATOLOGY
The use of molecular assays in the management of viral hepatitis2008Mangia, A; Antonucci, F; Brunetto, M; Capobianchi, M; Fagiuoli, S; Guido, M; Farci, Patrizia; Lam...pertico, P; Marzano, A; Niro, G; Pisani, G; Prati, D; Puoti, M; Raimondo, G; Santantonio, T; Smedile, A; Lauria, F; Italian Association for the Study of the, LiverDIGESTIVE AND LIVER DISEASE
Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a.2008Marcellin P; Lau GK; Zeuzem S; Heathcote EJ; Pockros PJ; Reddy KR; Piratvisuth T; Farci P; Chow W...C; Jia JD; Paik W; Wintfeld N; Pluck NLIVER INTERNATIONAL
Treatment of patients with Chronic Hepatitis Delta2007FARCI P.Marcellin Patrick
Treatment of chronic hepatitis D2007Farci P; Chessa L; Balestrieri C; Serra G; Lai MEJOURNAL OF VIRAL HEPATITIS
Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy2007Carta MG; Hardoy MC; Garofalo A; Pisano E; Nonnoi V; Intilla G; Serra G; Balestrieri C; Chessa L;... Cauli C; Lai ME; Farci PCLINICAL PRACTICE AND EPIDEMIOLOGY IN MENTAL HEALTH
Predicting response to peginterferon alfa-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B2007BONINO F; MARCELLIN P; LAU GK; HADZIYANNIS S; JIN R; PIRATVISUTH T; GERMANIDIS G; YURDAYDIN C; DI...AGO M; GUREL S; LAI MY; BRUNETTO M; FARCI P.; POPESCU M; MCCLOUD PGUT
In Vivo study of the HC-TN Strain of Hepatitis C Virus Recovered from a Case of Fulminant Hepatitis: RNA Transcripts of a Molecular Clone (pHC-TN) are Infectious in Chimpanzees but not in Huh7.5 cells2007SAKAI A; TAKIKAWA S; THIMME R; MEUNIER JC; SPANGENBERG HC; GOVINDARAJAN S; FARCI P.; EMERSON SU; ...CHISARI FV; PURCELL RH; BUKH JJOURNAL OF VIROLOGY
Hepatitis D (Delta) Virus2007TAYLOR J; FARCI P.; PURCELL RHLippincott Williams &Wilkins
Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin2006Cauli C; Serra G; Chessa L; Balestrieri A; Scioscia R; Lai ME; Farci PHAEMATOLOGICA
Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C2006PRATI D; SHIFFMAN ML; DIAGO M; GANE E; REDDY KR; POCKROS P; FARCI P.; OBRIEN CB; LARDELLI P; BLOT...NER S; ZEUZEM SJOURNAL OF HEPATOLOGY
Treatment of chronic hepatitis C in patients with glucose-6-phosphate dehydrogenase deficiency: is ribavirin harmful?2006Balestrieri C; Serra G; Cauli C; Chessa L; Balestrieri A; Farci PBLOOD
Treatment of chronic hepatitis D: New advances, old challenges2006FARCI P.HEPATOLOGY
Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively2006FARCI P.; QUINTI I; FARCI S; ALTER HJ; STRAZZERA R; PALOMBA E; COIANA A; CAO D; CASADEI AM; LEDDA... R; IORIO R; VEGNENTE A; DIAZ G; TOVO P-APROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase2006HORNBERGER J; FARCI P.; PRATI D; ZEUZEM S; GREEN J; PATEL KKJOURNAL OF VIRAL HEPATITIS
Immune Response to Hepatitis C Virus2005FARCI P.HEPATOLOGY REVIEW
Natural history and experimental models of hepatitis C2005FARCI P.; BUKH J; PURCELL RH.Blackwell Publishing
Chronic viral hepatitis D2005FARCI P.; LAI ME
Clinical relevance of hepatitis C virus genetic variability2004Farci P; Balestrieri C; Pirri A; Serra G; Chessa L; Lai ME; Purcell RH
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B2004MARCELLIN P; LAU GKK; BONINO F; FARCI P.; HADZIYANNIS S; JIN R; LU Z-M; PIRATVISUTH T; GERMANIDIS... G; YURDAYDIN C; DIAGO M; GUREL S; LAI M-Y; BUTTON P; PLUCK N.NEW ENGLAND JOURNAL OF MEDICINE
   
credits unica.it | accessibilità Università degli Studi di Cagliari
C.F.: 80019600925 - P.I.: 00443370929
note legali | privacy

Nascondi la toolbar